These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25882979)

  • 1. Persistent, Unexplained Leukocytosis Is a Paraneoplastic Syndrome Associated With a Poor Prognosis in Patients With Urothelial Carcinoma.
    Izard JP; Gore JL; Mostaghel EA; Wright JL; Yu EY
    Clin Genitourin Cancer; 2015 Aug; 13(4):e253-e258. PubMed ID: 25882979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial carcinoma with paraneoplastic leukocytosis.
    Hsu CW; Su HY
    Hong Kong Med J; 2017 Apr; 23(2):207.e3-4. PubMed ID: 28387206
    [No Abstract]   [Full Text] [Related]  

  • 4. Poor prognosis of urothelial carcinoma in patients presented with persistent paraneoplastic leukocytosis with anemia.
    Warli SM; Andy A; Prapiska FF; Siregar GP; Sihombing B
    Urol Ann; 2022; 14(4):328-331. PubMed ID: 36505981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence.
    Dukes JW; Tierney LM
    Urology; 2009 Apr; 73(4):928.e17-9. PubMed ID: 18718647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial cancers: using biology to improve outcomes.
    Pezaro C; Liew MS; Davis ID
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
    Mbeutcha A; Shariat SF; Rieken M; Rink M; Xylinas E; Seitz C; Lucca I; Mathieu R; Rouprêt M; Briganti A; Karakiewicz PI; Klatte T
    Urol Oncol; 2016 Nov; 34(11):483.e17-483.e24. PubMed ID: 27646875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Annular constriction of the rectum secondary to urothelial carcinoma of the bladder].
    Ito Y; Nishimoto K; Ogata K; Fujioka T
    Hinyokika Kiyo; 2008 Aug; 54(8):553-5. PubMed ID: 18788446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
    Buti S; Ciccarese C; Zanoni D; Santoni M; Modena A; Maines F; Gilli A; Bria E; Brunelli M; Rimanti A; Cascinu S; Ardizzoni A; Tortora G; Massari F
    Future Oncol; 2015; 11(1):107-19. PubMed ID: 25572786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A
    Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for urothelial (bladder) cancer.
    Cumberbatch K; He T; Thorogood Z; Gartrell BA
    Expert Opin Emerg Drugs; 2017 Jun; 22(2):149-164. PubMed ID: 28556678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukemoid reaction and hypercalcemia in carcinoma of the bladder].
    Alamé T; De Weweire A; Gris P; Coffernils M; Van den Heule B; Delmez JP; Longeval E
    Rev Med Brux; 1990 Mar; 11(3):59-62. PubMed ID: 2181581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.